Non-Human Primate (NHP) Research Platforms

When facing the immense challenges of preclinical drug development, researchers often grapple with long development cycles and the unpredictability of translating data from rodent models to human clinical trials. At Creative Biolabs, we address these critical pain points by offering an integrated suite of NHP Research Platforms, empowering our partners with highly predictable, human-relevant data. Our core value is accelerating the path to clinical success by leveraging advanced, ethically-sourced non-human primate models and a comprehensive technology stack that spans in vivo experimentation, advanced imaging, and state-of-the-art bioanalytical services.

NHP Research Platforms: The Next Generation of Translational Medicine

Bridging the gap between preclinical models and clinical outcomes with high-predictability NHP studies.

Overview of Our Platform

Creative Biolabs' NHP Research Platforms are a comprehensive suite of integrated solutions designed to accelerate preclinical drug, gene, and cell therapy development. Our platforms unify a diverse range of capabilities, from advanced in vivo and in vitro research to cutting-edge imaging and bioanalytical services. This cohesive approach allows for a single, continuous workflow, minimizing the logistical complexities and data silos that often hinder research progress.

What Are Our Platforms?

Creative Biolabs' NHP Research Platforms are a comprehensive, end-to-end preclinical solution for biopharma. Our services integrate advanced NHP models with cutting-edge technologies to generate highly relevant and predictive data. Application Scenarios of Our Platforms:

Gene Therapy Efficacy & Biodistribution: We track the in vivo distribution and effectiveness of gene therapies using advanced imaging and bioanalytical techniques.
Neurodegenerative Disease Modeling: We utilize NHP models to study complex neurological diseases, allowing for the precise evaluation of new therapeutics for conditions like Parkinson's or Alzheimer's.
Vaccine and Immunology Studies: Our platforms enable the evaluation of new vaccines and immunotherapies by monitoring immune responses and safety in a human-like system.

Why Choose Our Platforms?

Traditional preclinical models often struggle to predict human outcomes, leading to costly setbacks in clinical trials. Our NHP platforms solve this problem by providing data with significantly higher translational predictability due to the genetic and physiological similarities between NHPs and humans. By leveraging our services, you can derisk your R&D pipeline, improve the clinical translation of your therapies, and accelerate data acquisition for crucial regulatory submissions.

Key Benefits of Our Platforms

High Translational Predictability: NHP models closely mimic human physiology, ensuring that your preclinical data is more likely to translate successfully in clinical trials.
Integrated, End-to-End Solutions: Our platforms combine in vivo, in vitro, and bioanalytical services, eliminating the need for fragmented, multi-vendor studies.
Rapid Project Initiation & Execution: We provide a streamlined process and access to a large, ethically-sourced NHP colony, enabling faster study initiation and turnaround times.
Robust Data for Regulatory Submissions: Our rigorous scientific standards and comprehensive data packages provide the strong evidence required for successful Investigational New Drug (IND) applications.

Core Capabilities of Our Platforms

In Vivo Experimentation Facilities: Conducting complex studies for pharmacokinetics (PK), pharmacodynamics (PD), and toxicology.

Advanced Imaging & Monitoring Platforms: Tracking drug biodistribution and monitoring disease progression in real-time using technologies like PET/CT and MRI.

In Vitro & Ex Vivo Research Labs: Analyzing NHP-derived biological samples for biomarker discovery and validation.

Bioanalytical & Biomarker Analytics: Quantifying drug concentrations and metabolites with advanced mass spectrometry platforms.

Applications Enabled

Gene Therapy Biodistribution & Efficacy Studies
Neurodegenerative Disease Modeling
Immunology & Vaccine Development
Oncology and Tumor Biology
Infectious Disease Research
Cardiovascular and Metabolic Disorders

Deliverables

Processed imaging datasets in standardized formats.
Comprehensive pharmacology, PK/PD, and toxicology study reports
Statistical analysis summaries and raw data files.
QC logs and detailed metadata for each sample, including species and donor information.
Biological samples (plasma, tissues) from our extensive biobank for follow-on research.

Frequently Asked Questions

Q: What is the typical turnaround time for a standard PK/PD study?

A: Project timelines are customized based on complexity and specific requirements. We pride ourselves on rapid project initiation and efficient execution, and we can provide a detailed timeline after a brief consultation to understand your needs.

Q: How do you ensure the ethical sourcing and welfare of your NHP models?

A: We are committed to the highest standards of animal welfare. All our facilities adhere to stringent ethical guidelines, and our NHPs are sourced from regulated, ethical breeding programs, ensuring their well-being and the scientific integrity of your studies.

Q: Why should we choose NHP models over more cost-effective rodent models?

A: While rodents are valuable for early-stage research, NHP models offer superior translational relevance due to their genetic and physiological similarity to humans. This reduces the risk of expensive clinical trial failures and accelerates your path to market.

Q: Can you perform studies using our own custom protocols and assays?

A: Absolutely. Our platforms are designed for flexibility. We are equipped to perform studies based on your specific protocols and can also assist with custom assay development and validation to meet your unique research objectives.

Q: What kind of data will we receive upon study completion?

A: We provide a comprehensive data package that includes not only a final report with conclusions and analysis but also all raw data, processed files, and any requested biospecimens, ensuring complete transparency and reproducibility.

Contact Us

The Creative Biolabs NHP Research Platforms represent a robust, integrated, and highly predictive solution for modern drug development. By providing a single point of access to a full suite of preclinical services, we empower our partners to make more informed decisions, accelerate their pipelines, and bring life-changing therapies to patients faster. To discuss your research needs and learn how our platforms can benefit your next project, please contact us today.